IMDX
Insight Molecular Diagnostics Inc.$4.25+0.36 (+9.38%)Prev Close$3.84·MCap$154.8M·P/E—·Vol263.7K·Yield—
▲
Buys (12M)
2
$2.69M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$2.69M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Insight Molecular Diagnostics Inc. (IMDX) has been exclusively buying, with 2 insider purchases totaling $2.69M and 0 insider sales totaling $0.00. The most recent insider transaction was by BROADWOOD PARTNERS, L.P. (10 percent owner), who purchased $2.03M worth of shares on Apr 27, 2026. Insight Molecular Diagnostics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $154.8M.
IMDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | Buy | 570,184 | $3.56 | $2.03M2.1% OS | 12,684,884 |
| Apr 20, 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | Buy | 182,861 | $3.57 | $652.9K0.7% OS | 12,114,700 |
| Feb 11, 2025 | James Andrea S. | Chief Financial Officer | Buy | 97,561 | $2.05 | $200.0K | 151,231+182% |
| Feb 11, 2025 | SMITH PATRICK W | 10% Owner | Buy | 1,077,600 | $2.05 | $2.21M4.0% OS | 2,872,671+60% |
| Feb 10, 2025 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 5,165,695 | $2.05 | $10.59M19.2% OS | 11,410,100+83% |
| Feb 4, 2025 | SMITH PATRICK W | 10% Owner | Buy | 915 | $2.01 | $1.8K | 1,795,071 |
| Jan 31, 2025 | SMITH PATRICK W | 10% Owner | Buy | 4,198 | $2.01 | $8.4K | 1,794,156 |
| Jan 15, 2025 | SMITH PATRICK W | 10% Owner | Buy | 16,055 | $2.12 | $34.1K | 1,789,958 |
| Dec 27, 2024 | SMITH PATRICK W | 10% Owner | Buy | 90,219 | $2.13 | $192.2K | 1,773,903 |
| Dec 26, 2024 | Arno Andrew | Director | Buy | 12,500 | $2.11 | $26.4K | 81,554 |
| Dec 9, 2024 | James Andrea S. | Chief Financial Officer | Buy | 20,000 | $2.29 | $45.8K | 53,670+59% |
| Oct 4, 2024 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 1,315,339 | $2.95 | $3.88M4.9% OS | 6,244,405+27% |
| Oct 4, 2024 | James Andrea S. | Chief Financial Officer | Buy | 33,670 | $2.97 | $100.0K | 33,670 |
| Apr 15, 2024 | Arno Andrew | Director | Buy | 33,898 | $2.95 | $100.0K | 69,054+96% |
| Apr 15, 2024 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 2,420,000 | $2.92 | $7.06M9.0% OS | 4,929,066+96% |
| Apr 15, 2024 | Riggs Josh | CEO and President | Buy | 3,390 | $2.95 | $10.0K | 3,505New Position |
| Jun 15, 2023 | KINGSLEY ALFRED D | Director | Buy | 30,000 | $0.21 | $6.4K | 469,111 |
| Apr 7, 2023 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Buy | 663,000 | $0.30 | $200.0K2.5% OS | 8,090,202 |
| Apr 5, 2023 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 26,827,638 | $0.30 | $8.09M99.9% OS | 50,181,336+115% |
| Dec 28, 2022 | Arno Andrew | Director | Buy | 250,000 | $0.35 | $87.9K0.9% OS | 532,049+89% |
| Dec 28, 2022 | Gutfreund John Peter | Director | Buy | 75,000 | $0.33 | $24.7K | 75,000 |
| Dec 27, 2022 | KINGSLEY ALFRED D | Director | Buy | 25,000 | $0.29 | $7.1K | 439,111 |
| Aug 19, 2022 | Arno Andrew | Director | Buy | 7,500 | $0.90 | $6.8K | 15,000+100% |
| Aug 19, 2022 | Last Andrew J. | Director | Buy | 20,000 | $0.87 | $17.4K | 70,170+40% |
| Aug 18, 2022 | ANDREWS RONALD ASBURY | President & CEO | Buy | 40,000 | $0.96 | $38.4K | 333,212 |
| Aug 17, 2022 | Arno Andrew | Director | Buy | 150,000 | $0.96 | $144.1K0.6% OS | 282,049+114% |
| Aug 17, 2022 | Carter Jennifer L. | Director | Buy | 10,500 | $0.95 | $10.0K | 30,500+53% |
| Aug 17, 2022 | GRIFFITH MELINDA | Director | Buy | 10,000 | $1.00 | $10.0K | 30,000+50% |
| Aug 17, 2022 | Gutfreund John Peter | Director | Buy | 25,000 | $0.93 | $23.3K | 25,000 |
| Aug 17, 2022 | KINGSLEY ALFRED D | Director | Buy | 5,000 | $0.97 | $4.8K | 409,111 |
| Jun 28, 2022 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Sell | 99,386 | $1.03 | $102.6K | 8,520,146 |
| May 19, 2022 | Yu Li | VP Cntrllr/Prncpl Acctng Offcr | Sell | 8,128 | $1.14 | $9.3K | 16,872-33% |
| Apr 18, 2022 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Buy | 5,931,707 | $1.33 | $7.89M22.1% OS | 8,532,663+228% |
| Apr 15, 2022 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 6,003,752 | $1.33 | $8.00M22.4% OS | 23,353,696+35% |
| Mar 28, 2022 | Ross Douglas T. | Chief Scientific Officer | Buy | 15,000 | $1.40 | $21.0K | 20,317+282% |
| Mar 17, 2022 | ANDREWS RONALD ASBURY | Chief Executive Officer | Buy | 50,000 | $1.28 | $64.2K | 293,212 |
| Mar 17, 2022 | Paulsen Gisela | Chief Operating Officer | Buy | 16,500 | $1.20 | $19.8K | 16,500 |
| Mar 16, 2022 | Redmond Cavan M. | Director | Buy | 40,000 | $1.19 | $47.6K | 110,863+56% |
| Mar 15, 2022 | Levine Mitchell S | Chief Financial Officer | Buy | 25,000 | $1.17 | $29.1K | 87,080+40% |
| Mar 22, 2021 | ANDREWS RONALD ASBURY | Chief Executive Officer | Buy | 11,000 | $4.79 | $52.7K | 113,698 |
IMDX Insider Buying Activity
The following table shows recent insider purchases of Insight Molecular Diagnostics Inc. (IMDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | Buy | 570,184 | $3.56 | $2.03M2.1% OS | 12,684,884 |
| Apr 20, 2026 | BROADWOOD PARTNERS, L.P. | 10 percent owner | Buy | 182,861 | $3.57 | $652.9K0.7% OS | 12,114,700 |
| Feb 11, 2025 | James Andrea S. | Chief Financial Officer | Buy | 97,561 | $2.05 | $200.0K | 151,231+182% |
| Feb 11, 2025 | SMITH PATRICK W | 10% Owner | Buy | 1,077,600 | $2.05 | $2.21M4.0% OS | 2,872,671+60% |
| Feb 10, 2025 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 5,165,695 | $2.05 | $10.59M19.2% OS | 11,410,100+83% |
| Feb 4, 2025 | SMITH PATRICK W | 10% Owner | Buy | 915 | $2.01 | $1.8K | 1,795,071 |
| Jan 31, 2025 | SMITH PATRICK W | 10% Owner | Buy | 4,198 | $2.01 | $8.4K | 1,794,156 |
| Jan 15, 2025 | SMITH PATRICK W | 10% Owner | Buy | 16,055 | $2.12 | $34.1K | 1,789,958 |
| Dec 27, 2024 | SMITH PATRICK W | 10% Owner | Buy | 90,219 | $2.13 | $192.2K | 1,773,903 |
| Dec 26, 2024 | Arno Andrew | Director | Buy | 12,500 | $2.11 | $26.4K | 81,554 |
| Dec 9, 2024 | James Andrea S. | Chief Financial Officer | Buy | 20,000 | $2.29 | $45.8K | 53,670+59% |
| Oct 4, 2024 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 1,315,339 | $2.95 | $3.88M4.9% OS | 6,244,405+27% |
| Oct 4, 2024 | James Andrea S. | Chief Financial Officer | Buy | 33,670 | $2.97 | $100.0K | 33,670 |
| Apr 15, 2024 | Arno Andrew | Director | Buy | 33,898 | $2.95 | $100.0K | 69,054+96% |
| Apr 15, 2024 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 2,420,000 | $2.92 | $7.06M9.0% OS | 4,929,066+96% |
| Apr 15, 2024 | Riggs Josh | CEO and President | Buy | 3,390 | $2.95 | $10.0K | 3,505New Position |
| Jun 15, 2023 | KINGSLEY ALFRED D | Director | Buy | 30,000 | $0.21 | $6.4K | 469,111 |
| Apr 7, 2023 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Buy | 663,000 | $0.30 | $200.0K2.5% OS | 8,090,202 |
| Apr 5, 2023 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 26,827,638 | $0.30 | $8.09M99.9% OS | 50,181,336+115% |
| Dec 28, 2022 | Arno Andrew | Director | Buy | 250,000 | $0.35 | $87.9K0.9% OS | 532,049+89% |
| Dec 28, 2022 | Gutfreund John Peter | Director | Buy | 75,000 | $0.33 | $24.7K | 75,000 |
| Dec 27, 2022 | KINGSLEY ALFRED D | Director | Buy | 25,000 | $0.29 | $7.1K | 439,111 |
| Aug 19, 2022 | Arno Andrew | Director | Buy | 7,500 | $0.90 | $6.8K | 15,000+100% |
| Aug 19, 2022 | Last Andrew J. | Director | Buy | 20,000 | $0.87 | $17.4K | 70,170+40% |
| Aug 18, 2022 | ANDREWS RONALD ASBURY | President & CEO | Buy | 40,000 | $0.96 | $38.4K | 333,212 |
| Aug 17, 2022 | Arno Andrew | Director | Buy | 150,000 | $0.96 | $144.1K0.6% OS | 282,049+114% |
| Aug 17, 2022 | Carter Jennifer L. | Director | Buy | 10,500 | $0.95 | $10.0K | 30,500+53% |
| Aug 17, 2022 | GRIFFITH MELINDA | Director | Buy | 10,000 | $1.00 | $10.0K | 30,000+50% |
| Aug 17, 2022 | Gutfreund John Peter | Director | Buy | 25,000 | $0.93 | $23.3K | 25,000 |
| Aug 17, 2022 | KINGSLEY ALFRED D | Director | Buy | 5,000 | $0.97 | $4.8K | 409,111 |
| Apr 18, 2022 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Buy | 5,931,707 | $1.33 | $7.89M22.1% OS | 8,532,663+228% |
| Apr 15, 2022 | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | 6,003,752 | $1.33 | $8.00M22.4% OS | 23,353,696+35% |
| Mar 28, 2022 | Ross Douglas T. | Chief Scientific Officer | Buy | 15,000 | $1.40 | $21.0K | 20,317+282% |
| Mar 17, 2022 | ANDREWS RONALD ASBURY | Chief Executive Officer | Buy | 50,000 | $1.28 | $64.2K | 293,212 |
| Mar 17, 2022 | Paulsen Gisela | Chief Operating Officer | Buy | 16,500 | $1.20 | $19.8K | 16,500 |
| Mar 16, 2022 | Redmond Cavan M. | Director | Buy | 40,000 | $1.19 | $47.6K | 110,863+56% |
| Mar 15, 2022 | Levine Mitchell S | Chief Financial Officer | Buy | 25,000 | $1.17 | $29.1K | 87,080+40% |
| Mar 22, 2021 | ANDREWS RONALD ASBURY | Chief Executive Officer | Buy | 11,000 | $4.79 | $52.7K | 113,698 |
IMDX Insider Selling Activity
The following table shows recent insider sales of Insight Molecular Diagnostics Inc. (IMDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 28, 2022 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Sell | 99,386 | $1.03 | $102.6K | 8,520,146 |
| May 19, 2022 | Yu Li | VP Cntrllr/Prncpl Acctng Offcr | Sell | 8,128 | $1.14 | $9.3K | 16,872-33% |
IMDX Insiders
Similar Stocks to IMDX
VRTX
Vertex Pharmaceuticals Incorporated
$429.19+0.77%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$740.38-0.55%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$305.79-0.88%
$41.24B
INSM
Insmed Incorporated
$133.47-1.85%
$30.79B
RVMD
Revolution Medicines, Inc.
$146.58+11.18%
$29.51B
UTHR
United Therapeutics Corporation
$566.52-0.06%
$25.13B
MRNA
Moderna, Inc.
$46.88-3.78%
$21.42B
RPRX
Royalty Pharma plc
$49.86+0.42%
$21.20B